crossorigin="anonymous">

​​South Korean AI imaging startup AIRS Medical scores $20M in Series B funding



Clinical AI startup AIRS Clinical from South Korea has raised $20 million in a Sequence B investment spherical participated by means of its new buyers Q Capital Companions and Hanwha Existence and its current investor Klim Ventures.

WHAT IT DOES

Based in 2018, the startup gives AI-based diagnostic exams and robot applied sciences that reinforce each affected person and healthcare supplier revel in. 

Its flagship product, SwiftMR, is an AI-powered MRI reconstruction tool that complements MR photographs. Since its release remaining yr, the tool as a scientific instrument has been utilized in greater than 130,000 MRI examinations in South Korea. The tool has been authorized by means of the South Korean Ministry of Meals and Drug Protection and america Meals and Drug Management. 

AIRS Clinical may be growing an automatic resolution for venipuncture known as AIIV, which is lately being examined in scientific settings in South Korea. 

Since obtaining fellow South Korean AI startup artiQ in March, the corporate has added in-vitro diagnostics to its generation portfolio.

WHAT IT’S FOR

Consistent with a press unlock, the startup’s newest investment will pass to its international enlargement efforts. In the course of the fortify of each startup accelerator Born2Global and the KOSME-MATTER US Marketplace Adoption Program, AIRS Clinical has been introducing SwiftMR in america, Europe, Southeast Asia, and Latin The us.

“In the course of the Sequence B investment we have secured, we can be taking our leading edge diagnostic answers to the worldwide marketplace,” mentioned CEO Hye-Seong Lee.

MARKET SNAPSHOT

South Korea’s scientific AI panorama is lately ruled by means of two corporations that experience lately long past public. Ultimate yr, VUNO raised $33.6 million from its preliminary public providing. Since then it has gained clearance from more than a few regulatory businesses, in addition to partnerships to combine its AI scientific imaging answers.

In July this yr, Lunit debuted at the buying and selling board of the Korea Change, elevating $37 million. Previous to its IPO, the corporate has been securing contracts in a foreign country to roll out its AI radiology answers.

The international marketplace for AI in healthcare is predicted to achieve $67 billion in worth by means of 2027 from $6.9 billion remaining yr, rising at a 46% CAGR.


crossorigin="anonymous">
Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *